Fortune, November 5, 2021: The lack of diversity in clinical trials is standing in the way of medical advancement. NCHR president Dr. Diana Zuckerman explains how that delayed progress in treating triple negative breast cancer, which is more common among Black women.
Read More »Tag: research
‘Bad advice from the president’: Trump touts unproven coronavirus drugs
Politico: March 20, 2020. We find that the president’s suggested programs allowing the administration to get experimental drugs to people quickly outside of clinical trials is bad advice.
Read More »